Summit moderator Dennis Scanlon, PhD, asked the panelists to sum up their thoughts from the day’s discussions.
“At this point, the [Centers for Medicare & Medicaid Services] and the [Center for Medicare Innovation] in particular should ratchet back” their efforts, declares Francois de Brantes, executive director of the Healthcare Incentives Improvement Institute. He sees their efforts as too many fits and starts, and although they have moved the needle on reform, none of the individual initiatives can be rated “a stellar A.” Over the next 4 to 5 years, innovations in the private sector will serve as a primary engine and the federal government can learn what works with the models as they evolve, he adds. The delivery system can be fully transformed when other innovations emerge, and we will learn from that, predicts Mr de Brantes.
There is no final solution so far regarding healthcare costs, according to Arthur Vercillo, MD, FACS, regional president of Excellus Blue Cross Blue Shield, although the ACA has led to consumers having more skin in the game, which he believes will make a difference. However, the real game is to maintain or improve the quality of healthcare while holding down costs. “We know what the cost drivers are, and they need to be attacked individually,” he states.
Even though accessibility with the ACA is progressing, Dr Vercillo says we are not there yet, although over the next few years “We’ll be in a much better place when it comes to quality, cost and accessibility, and we need to.”
Ateev Mehrotra, MD, MPH, associate professor of healthcare policy and medicine at Harvard Medical School and a hospitalist at Beth Israel Deaconess Medical Center agrees with Mr de Brantes’ assessment of the ACA approach of trying different avenues to manage healthcare spending. He points to patient-centered medical homes, which sound rational in theory but have not had much of an impact. “We just can’t go based on theory anymore. We have to say, ‘Okay, the evidence is that a particular intervention didn’t work. Maybe ACOs did work. Let’s put more of our energy there.’” We must eliminate programs that are not working, he emphasizes.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Health Equity and Access Weekly Roundup: April 27, 2024
April 27th 2024Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More